Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer stage IV colon adenocarcinoma: Implications for a standardized scoring system

Cancer

Volumn 92, Issue 5, 2001, Pages 1331-1346

  Zent, Clive S ^a   Kyasa, Mouhammed J ^a   Evans, Richard ^b   Schichman, Steven A ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Adenocarcinoma; Colon; Epidermal growth factor receptor (EGFR); Immunohistochemistry; Monoclonal therapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; COLON ADENOCARCINOMA; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STANDARDIZATION;

ADENOCARCINOMA; COLONIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0035447953     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M     Document Type: Article

References (64)

1. A neu acquaintance for erbB3 and erbB4: A role for receptor heterodimerization in growth signaling
2. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer
3. Epidermal growth factor
4. Receptors for epidermal growth factor and other polypeptide mitogens
5. Transforming growth factor alpha and beta expression in human colon cancer lines: Implications for an autocrine model
6. Tyrosine phosphorylation and the regulation of cell growth: Growth factor-stimulated tyrosine phosphorylation of phospholipase C
7. Role of growth factors and their receptors in the control of normal cell proliferation and cancer
8. Characterization and control of EGF-stimulated formation of inositol phosphates in A-431 cells
9. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor
10. Antitumor activity of sequential treatment with topotecan and anti- epidermal growth factor receptor monoclonal antibody C225
11. Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells
12. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A
13. Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies
14. Continuous administration of ZD1839 (Iressa), a novel oral epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), in patients with five selected tumor types: Evidence of activity and good tolerability
15. Intermittent oral ZD1839 (Iressa), a novel epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), shows early evidence of good tolerability and activity: Final results from a phase I study
16. Monoclonal antibody (MoAb) IMC-C225 an anti-epidermal growth factor receptor (EGFr) for patients (Pts) with EGFr-positive tumors refractory to or in relapse from previous therapeutic regimens
17. The prognostic importance of peritoneal involvement in colonic cancer: A prospective evaluation
18. Histologic features associated with lymph node metastasis in stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resection specimens. Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdominoperineal resection should be considered after local excision
19. The grading and prognosis of carcinoma of the colon and rectum
20. The grading of rectal cancer: Historical perspectives and a multivariate analysis of 447 cases
21. Reporting colorectal cancer
22. Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas. An immunohistological study of 63 cases
23. Pericolonic tumor deposits in patients with T3N+MO colon adenocarcinomas: Markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification
24. Testing for erbB-2 by immunohistochemistry in breast cancer
25. EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma
26. Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue
27. Expression of epidermal growth factor receptor messenger RNA in human colorectal carcinomas assessed by non-radioactive in-situ hybridization
28. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor content in normal and carcinomatous gastric and colonic tissue
29. Sex steroid hormone receptors, epidermal growth factor receptor, and polyamines in human colorectal cancer
30. Expression of several growth factors and their receptor genes in human colon carcinomas
31. Epidermal growth factor receptors and epidermal growth factor-like activity in colorectal mucosa, adenomas and carcinomas
32. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas
33. Expression of TGF-alpha/EGF and TGF-beta receptors in human colon carcinoma cell lines
34. Epidermal growth factor receptors in colorectal carcinoma
35. Receptors for epidermal growth factor and sex steroid hormones in human colorectal carcinomas
36. Expression of epidermal growth factor receptor in normal colonic mucosa and in adenocarcinomas of the colon
37. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues
38. Increased expression of the epidermal growth factor receptor on human colon carcinoma cells
39. In situ evaluation of the relationship between epidermal-growth-factor-receptor status and tumor-cell proliferation in colon carcinomas
40. Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: Validation against ligand-binding assay and clinical relevance in breast cancer
41. Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma
42. Epidermal growth factor receptor expression in colorectal cancer
43. Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer
44. Prognostic markers of colorectal cancer: An evaluation of DNA content, epidermal growth factor receptor, and Ki-67
45. Ras gene activation and epidermal growth factor receptor expression in human colon cancer
46. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas
47. Immunohistochemical detection of epidermal growth factor receptors on human colonic carcinomas
48. A new prognostic classification of rectal cancer
49. Prognostic value of tumor "budding" in patients with colorectal cancer
50. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer
51. Indicators for treatment strategies of colorectal liver metastases
52. Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment
53. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells
54. Molecular determinants in the biology of liver metastasis
55. Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis
56. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer
57. Epidermal growth factor receptor expression in primary cultured human colorectal carcinoma cells
58. Analysis of colorectal cancer by comparative genomic hybridization: Evidence for induction of the metastatic phenotype by loss of tumor suppressor genes
59. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases
60. Preferential activation of the epidermal growth factor receptor in human colon carcinoma liver metastases in nude mice
61. Expression of growth factor receptors is not a prognostic indicator in young patients with colorectal cancer
62. Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas
63. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2
64. Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines